We found that CELF2 expression exerted a positive effect on both OS and RFS in breast cancer and was significantly correlated with ER, PR, HER2 status, subtype, grade, lymph node status and TP53 status of patients (Table 1). The gene discussed is CELF2; the disease is breast carcinoma.